National Institutes of Health (NIH) — 2013 Investments

36 investments dated 2013 · listed companies and verified rows first · show all

Savarasavarapharma.cominNASDAQ: SVRAMar 2013 · $4.5M

Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.

BiotechHealthtechMedical DevicesAustin, US

Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)Richard J. Hawkins(Director)An van Es-Johansson(Director)Ricky Sun(Director)Taneli Jouhikainen(Executive Officer)Mike Ciesla(Executive Officer)

ACTUATED MEDICAL, INC.actuatedmedical.comJan 2013 · $35.8M

AKONNI BIOSYSTEMS INCakonni.comJun 2013 · $20.6M

AVATAR MEDICAL, LLCavatarbiotechnologies.comSep 2013 · $6.8M

BIOMARCK PHARMACEUTICALS, LTDbiomarck.comAug 2013 · $6.5M

BIOPICO SYSTEMS Inc.biopico.comSep 2013 · $3.8M

Biospyder Technologies, Inc.biospyder.comSep 2013 · $17.4M

BOLDER BIOTECHNOLOGY INCbolderbio.comMar 2013 · $23.4M

Capricorcapricor.comin 𝕏Sep 2013 · $8.4M

Capricor Therapeutics is a biotechnology company developing allogeneic cardiosphere-derived cell (CDC) and exosome-based therapeutics to treat serious diseases including Duchenne muscular dystrophy.

BiotechMedical Devices

COLLABORATIVE DRUG DISCOVERY, INC.collaborativedrug.comAug 2013 · $14.4M

Delpordelpor.cominSep 2013 · $14.1M

Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment.

BiotechHealthtechMedical Devices

Gigagen, Inc.gigagen.comSep 2013 · $10.1M

GLYCOSENSORS AND DIAGNOSTICS, LLClectenz.comSep 2013 · $11.1M

Health Outcomes Inctelesage.comApr 2013 · $10.3M

IMMUNEXT PHARMACEUTICALSimmunext.comMar 2013 · $17.2M

INFINITE BIOMEDICAL TECHNOLOGIES, LLCi-biomed.comMar 2013 · $30.8M

INTEGRAL MOLECULAR INCintegralmolecular.comDec 2013 · $28.8M

INTELLIGENT FIBER OPTIC SYSTEMS CORPifos.comAug 2013 · $6M

INTELLIGENT OPTICAL SYSTEMS, INC.intopsys.comSep 2013 · $20.3M

IS3D LLCcogenteducation.comJul 2013 · $3.9M

JBS SCIENCE INCjbs-science.comAug 2013 · $9.6M

KITWARE INCkitware.comSep 2013 · $45.2M

MICHIGAN CRITICAL CARE CONSULTANTS, INC.mc3corp.comSep 2013 · $29.4M

MICROVI BIOTECH, INC.microvi.comDec 2013 · $5.6M

Modulimmodulim.comin 𝕏Jun 2013 · $9.9M

MY COVERAGE PLAN INC.mycoverageplan.comSep 2013 · $2M

NAPROGENIX, INC.naprogenix.comSep 2013 · $17.5M

ORBIS BIOSCIENCES, INC.orbisbio.comSep 2013 · $6.2M

PAUL H BROOKES PUBLISHING CO., INC.brookespublishing.comDec 2013 · $2.4M

PRIMITY BIO, INC.primitybio.comJul 2013 · $8.9M

SANARIA INC.sanaria.comAug 2013 · $90.6M

Sofie Biosciences, Inc.sofiebio.comSep 2013 · $8.8M

TECHSHOT, INC.techshot.comSep 2013 · $9.3M

TREVIGEN, INC.trevigen.comSep 2013 · $10.2M

VENATORX PHARMACEUTICALS INCvenatorx.comAug 2013 · $30.8M

VORTANT TECHNOLOGIES LLCvortant.comFeb 2013 · $5.4M

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.